| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/11/2005 | US20050176640 poxvirus protein A41L binds to leukocyte common-antigen-related protein; monoclonal antibody; therapeutic agents for an immune and/or inflammatory response; poxvirus |
| 08/11/2005 | US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 08/11/2005 | US20050176638 Product derived from milk substantially free of beta casein from non-human mammals and relative use |
| 08/11/2005 | US20050176637 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 08/11/2005 | US20050176636 Peptides of 38 amino acids, including therein a sequence of L-K-E-K-K, have physiological activity that can be wound healing activity, immunostimulant activity, or stimulating pituitary/hypothalamus activity in a mammal |
| 08/11/2005 | US20050176634 substitution or the elimination ofcysteine residue (Cys) in the C-terminal portion of the wild type protein polypeptide sequence; prevents multimerisation of monomeric form but does not affect dimerisation; storage stability; treatment of ischemia, scleroderma, skin ulcer, aging, burn, wound; cosmetic |
| 08/11/2005 | US20050176632 Angiogenesis inhibitors |
| 08/11/2005 | US20050176629 Telomerase expression repressor proteins and methods of using the same |
| 08/11/2005 | US20050176625 Synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 08/11/2005 | US20050176621 Crystalline compositions for controlling blood glucose |
| 08/11/2005 | US20050176130 Functional mutations in respiratory syncytial virus |
| 08/11/2005 | US20050176128 Method for assembling subunits into capsoids |
| 08/11/2005 | US20050176127 Primers; plasmid libraries; citrate synthases; glutamate dehydrogenases; phosphofructokinases |
| 08/11/2005 | US20050176126 Lachrymatory-factor synthase for use in identifying medicants for dry eye; producing onions with reduced lachrymatory factor and eye stinging |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050176114 Escherichia coli can produce L-threonine and includes prokaryotic and eukaryotic microorganisms having an inactivated galR gene |
| 08/11/2005 | US20050176113 Microorganism producing L-threonine having inactivated tyrR gene, method of producing the same and method of producing L-threonine using the microorganism |
| 08/11/2005 | US20050176106 Use of the RTX secretion system to achieve heterologous polypeptide secretion by Vibrio cholerae |
| 08/11/2005 | US20050176105 Used in cell culture media, and as inhibitors of protease-mediated degradation of plasma proteins in protein purification; fewer side effects than traditional anticoagulants |
| 08/11/2005 | US20050176104 Using overexpression of nucleotide sequences coding tumor associated antigen as diagnostic/prognostic tool in detection of cancer |
| 08/11/2005 | US20050176103 Produced by recombinant techniques and polynucleotides encoding the polypeptides; used to stimulate angiogenesis for wound healing and for vascular tissue repair |
| 08/11/2005 | US20050176102 Totipotent hematopoietic stem cell receptors and their ligands |
| 08/11/2005 | US20050176098 Human ion channels |
| 08/11/2005 | US20050176097 Bacterial bioreactor for propagation of enzymatic polypeptides |
| 08/11/2005 | US20050176095 Sulfur-assimilating regulatory protein for use as tool in controlling transgenic cells expressing heterologous gene sequences |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050176091 Process for producing kiss-1 peptide |
| 08/11/2005 | US20050176090 Method for flocculation of a fermentation broth comprising a fungus |
| 08/11/2005 | US20050176085 Isolating peptides not containing His or Arg and determining concentration involving hydrolysis; chemical modification of alpha and epsilon amino groups; isolation by cation exchange chromatography; identification by mass spectrometry; differential isotopic labeling and relative quantification |
| 08/11/2005 | US20050176080 quantitative analysis of tacrolimus |
| 08/11/2005 | US20050176077 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 08/11/2005 | US20050176075 Mdm2 splice variants |
| 08/11/2005 | US20050176070 Immunoglobulin array for use in monitoring polypeptide binding |
| 08/11/2005 | US20050176069 Drug screening; neuropeptides; ligands; mimetics; anthelmin-tics; use for screening and identification of materials that inhibit/interfer with the neurological activity of targeted invertebrates while minimizing effects on non-pest species |
| 08/11/2005 | US20050176062 Method of identifying ligands for nuclear receptors |
| 08/11/2005 | US20050176061 Using signal sequence polypeptide to diagnose/prognose diabetic disorders; antidiabetic agents |
| 08/11/2005 | US20050176047 Expression vector comprising regulatory sequences associated with tissue specific expression of ovomucoid gene for use as a gene expression control elements in heterologous gene transfer and transcription in birds |
| 08/11/2005 | US20050176044 Polynucleotides and polypeptides encoding receptors |
| 08/11/2005 | US20050176041 Using membrane proteins as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/11/2005 | US20050176021 Vectors for propagating and expressing RGL3 nucleic acids, host cells comprising the nucleic acids; proteins; cancer |
| 08/11/2005 | US20050176020 I-CAM related protein |
| 08/11/2005 | US20050176015 Anticancer agents; antiproliferative agents: monitoring mutant oncogenes; detecting cancer; signal amplification |
| 08/11/2005 | US20050176013 Identifying modulators of 3'-phosphoadenosine 5'-phosphosulfate synthase 1(PAPPS-1) activity; antitumor agents; tumor diagnostics |
| 08/11/2005 | US20050176010 Regulation of human transient receptor potential channel |
| 08/11/2005 | US20050176009 Polymorphic olfactory receptor genes and arrays, kits and methods utilizing information derived therefrom for genetic typing of individuals |
| 08/11/2005 | US20050176004 Rheumatoid arthritis disease sensitive gene, its protein, method and kit of judging the onset of rheumatoid arthritis using the same, and method and drugs for treating rheumatoid arthritis |
| 08/11/2005 | US20050176001 Using 16S ribosomal RNA as diagnostic tool in identifyin and classifying microorganism; food safety and quality control |
| 08/11/2005 | US20050175994 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
| 08/11/2005 | US20050175985 Cold-adapted equine influenza viruses |
| 08/11/2005 | US20050175635 Method and composition |
| 08/11/2005 | US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV |
| 08/11/2005 | US20050175632 Vaccine for preventing cervical cancer |
| 08/11/2005 | US20050175631 Hiv vaccine and method of use |
| 08/11/2005 | US20050175627 HIV pharmaccines |
| 08/11/2005 | US20050175626 Determining susceptibility; screening for clearance of deposition materials; developing antibodies |
| 08/11/2005 | US20050175624 Utilizing vascular epithelial growth factor (VEGFR1) polypeptides, fragments and/or encoding oligonucleotides |
| 08/11/2005 | US20050175621 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 08/11/2005 | US20050175620 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 08/11/2005 | US20050175617 Tie-2 ligands, methods of making and uses thereof |
| 08/11/2005 | US20050175612 Growth differentiation factor-8 |
| 08/11/2005 | US20050175610 Modified chimeric polypeptides with improved pharmacokinetic properties and methods of making and using thereof |
| 08/11/2005 | US20050175607 Novel nucleic acids and polypeptides |
| 08/11/2005 | US20050175605 Screening methods using a novel human EP prostaglandin receptor |
| 08/11/2005 | US20050175594 Myoviridae; also used to treat animals infected with Listeria monocytogenes |
| 08/11/2005 | US20050175591 For efficient mRNA termination/translation; using this shorter dual termination/polyadenylation signal and avoiding the need for large and cumbersome polyadenylation signals, expression vectors may be engineered to carry considerably larger genes |
| 08/11/2005 | US20050175590 Viral expression vectors |
| 08/11/2005 | US20050175588 Contain one or more recombinant molecule(s) expressed on a cellular surface and incorporated and/or associated with a particle that does not require cellular entry for delivery; for stimulation of biological processes, inactivation of inhibitory factors, scavenging and/or detoxifying |
| 08/11/2005 | US20050175587 Inhibits cancer cell growth especially epithelial cancer cell growth; host cell and a drug containing the vector; for the treatment of cancers, by gene therapy |
| 08/11/2005 | US20050175584 Functionalized colloidal metal compositions and methods |
| 08/11/2005 | US20050175582 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 08/11/2005 | US20050175553 new members of the TGF- beta protein family with mitogenic and/or differentiation-inductive potential; pharmaceutical composition further comprising a growth/differentiation factor selected from the group consisting of MP-121, epidermal growth factor and platelet derived growth factor |
| 08/11/2005 | US20050172424 Lmt turmor suppressor gene |
| 08/11/2005 | CA2595619A1 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide |
| 08/11/2005 | CA2554825A1 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | CA2554755A1 Functionalized colloidal metal compositions and methods |
| 08/11/2005 | CA2554623A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer |
| 08/11/2005 | CA2554599A1 Novel brain natriuretic peptide variants and methods of use thereof |
| 08/11/2005 | CA2554475A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 08/11/2005 | CA2554458A1 The combined use of glp-1 agonists and gastrin for regulating blood glucose levels |
| 08/11/2005 | CA2554440A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer |
| 08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
| 08/11/2005 | CA2554403A1 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | CA2554216A1 Methods and compositons for treating cancer |
| 08/11/2005 | CA2554035A1 Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides |
| 08/11/2005 | CA2553989A1 Production of host cells containing mutiple integrating vectors by serial transduction |
| 08/11/2005 | CA2553676A1 Human soluble neuropilin-1 primary polyadenylation signal and uses thereof |
| 08/11/2005 | CA2553187A1 Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility |
| 08/10/2005 | EP1561822A1 Detection of DNA damaging agents |
| 08/10/2005 | EP1561818A1 Nucleic acids and polypeptides of drosophila melanogaster SNF sodium-neurotransmitter symporter family cell surface receptors and methods of use |
| 08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
| 08/10/2005 | EP1561814A1 Gene expressed specifically in dopamine-producing neuron precursor cells after termination of division |
| 08/10/2005 | EP1561811A1 Microorganism producing L-threonine having inactivated galR gene, method of producing the same and method of producing L-threonine using the microorganism |
| 08/10/2005 | EP1561809A2 Eucaryotic cell expressing phycocyanin |
| 08/10/2005 | EP1561759A1 Cell death-inducing agent |
| 08/10/2005 | EP1561758A1 Method for isolating and purifying viruses from plant sources |
| 08/10/2005 | EP1561757A1 Modified factor VIII |
| 08/10/2005 | EP1561756A1 Method of purifying protein |
| 08/10/2005 | EP1561755A2 Method for derivatizing protein or peptide to sulfonic acid derivative |
| 08/10/2005 | EP1561470A1 HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| 08/10/2005 | EP1561117A1 Diagnostic and therapeutic use of arl7 for alzheimer's disease |